Literature DB >> 22644105

Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.

Yasuhiko Igawa1, Tim Schneider, Yoshinobu Yamazaki, Satoshi Tatemichi, Yukio Homma, Osamu Nishizawa, Martin C Michel.   

Abstract

This study aimed to characterize the β-adrenoceptor (β-AR) subtype mediating relaxation of isolated human bladder strips and to explore relaxation by the novel β3-AR-selective agonist KUC-7322 for its relaxant effect on the human isolated detrusor and for its effect on the carbachol (CCh)-induced contractile response. In two parallel studies, relaxation of isolated human bladder strips was tested for the β-AR agonists isoproterenol, clenbuterol, BRL 37344, and KUC-7322. For the isoproterenol and KUC-7322 responses, antagonism by CGP 20712A, ICI 118551, and SR59230A was determined. The potency and efficacy of the reference agonists for detrusor relaxation was in line with their known β3-AR activity. KUC-7322 relative to isoproterenol was a full agonist with a pEC(50) of 5.95 ± 0.09 and 5.92 ± 0.11 in the two studies. SR59230A exhibited antagonism of the expected potency against isoproterenol (apparent pK (B) 7.2) but not against KUC-7322. Neither isoproterenol nor KUC-7322 nor forskolin significantly attenuated CCh-induced contraction. These results suggest that KUC-7322 displays full agonistic activity in relaxing the human detrusor without inhibiting the contraction induced by cholinergic stimulation. These characteristics, if proven in vivo, may be beneficial for the treatment of overactive bladder, as increased bladder capacity with a negligible effect on voiding contractions may be anticipated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22644105     DOI: 10.1007/s00210-012-0763-x

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  42 in total

Review 1.  β-adrenoceptor agonist effects in experimental models of bladder dysfunction.

Authors:  Martin C Michel; Peter Ochodnicky; Yukio Homma; Yasuhiko Igawa
Journal:  Pharmacol Ther       Date:  2011-04-12       Impact factor: 12.310

2.  Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African Americans.

Authors:  Inna Belfer; Beata Buzas; Catherine Evans; Heather Hipp; Gabriel Phillips; Julie Taubman; Ilona Lorincz; Robert H Lipsky; Mary-Anne Enoch; Mitchell B Max; David Goldman
Journal:  Eur J Hum Genet       Date:  2005-03       Impact factor: 4.246

3.  Do gene polymorphisms alone or in combination affect the function of human beta3-adrenoceptors?

Authors:  Wim Vrydag; Astrid E Alewijnse; Martin C Michel
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

4.  Urothelial beta-3 adrenergic receptors in the rat bladder.

Authors:  F Aura Kullmann; Thomas R Downs; Debra E Artim; Brian J Limberg; Mansi Shah; Dan Contract; William C de Groat; Jan S Rosenbaum
Journal:  Neurourol Urodyn       Date:  2011-01       Impact factor: 2.696

5.  The effects of a new selective beta3-adrenoceptor agonist (GW427353) on spontaneous activity and detrusor relaxation in human bladder.

Authors:  Suzanne M Biers; John M Reynard; Alison F Brading
Journal:  BJU Int       Date:  2006-10-09       Impact factor: 5.588

6.  Desirable properties of β3-adrenoceptor agonists: implications for the selection of drug development candidates.

Authors:  Martin C Michel; Hana Cernecka; Peter Ochodnicky
Journal:  Eur J Pharmacol       Date:  2011-02-12       Impact factor: 4.432

7.  Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists.

Authors:  Masaaki Sato; Takahiro Horinouchi; Dana S Hutchinson; Bronwyn A Evans; Roger J Summers
Journal:  Mol Pharmacol       Date:  2007-08-23       Impact factor: 4.436

8.  Effects of a novel beta(3)-adrenoceptor agonist, AJ-9677, on relaxation of the detrusor muscle: an in vitro study.

Authors:  Atsushi Otsuka; Hitoshi Shinbo; Ko Hasebe; Rikiya Matsumoto; Seiichiro Ozono
Journal:  Int J Urol       Date:  2008-12       Impact factor: 3.369

9.  Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene.

Authors:  J Walston; K Silver; C Bogardus; W C Knowler; F S Celi; S Austin; B Manning; A D Strosberg; M P Stern; N Raben
Journal:  N Engl J Med       Date:  1995-08-10       Impact factor: 91.245

10.  Relaxation of human detrusor muscle by selective beta-2 and beta-3 agonists and endogenous catecholamines.

Authors:  Jasmin Katrin Badawi; Tobias Seja; Hatice Uecelehan; Patrick Honeck; Sun-Tscheol Kwon; Stephan Bross; Sigrun Langbein
Journal:  Urology       Date:  2007-04       Impact factor: 2.649

View more
  10 in total

1.  How significant are your data? The need for a culture shift.

Authors:  Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-30       Impact factor: 3.000

2.  Pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in cynomolgus monkeys.

Authors:  Toshiki Hatanaka; Masashi Ukai; Mai Watanabe; Akiyoshi Someya; Akiyoshi Ohtake; Masanori Suzuki; Koji Ueshima; Shuichi Sato; Noriyuki Masuda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-07-06       Impact factor: 3.000

Review 3.  Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline?

Authors:  Emilio Sacco; Riccardo Bientinesi
Journal:  Int Urogynecol J       Date:  2014-11-07       Impact factor: 2.894

4.  Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?

Authors:  Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-10       Impact factor: 3.000

5.  Rat β₃-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues.

Authors:  Hana Cernecka; Wisuit Pradidarcheep; Wouter H Lamers; Martina Schmidt; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-30       Impact factor: 3.000

6.  BRL37344, a β3-adrenergic receptor agonist, decreases nerve-evoked contractions in human detrusor smooth muscle isolated strips: role of BK channels.

Authors:  Serge A Y Afeli; Eric S Rovner; Georgi V Petkov
Journal:  Urology       Date:  2013-07-26       Impact factor: 2.649

7.  Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome.

Authors:  Yasuhiko Igawa; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-21       Impact factor: 3.000

Review 8.  The efficacy and tolerability of mirabegron, a β3 adrenoceptor agonist, in patients with symptoms of overactive bladder.

Authors:  Ganesh Thiagamoorthy; Stephanie Kotes; Martino Zacchè; Linda Cardozo
Journal:  Ther Adv Urol       Date:  2016-02

Review 9.  Everything You Always Wanted to Know about β3-AR * (* But Were Afraid to Ask).

Authors:  Giorgia Schena; Michael J Caplan
Journal:  Cells       Date:  2019-04-16       Impact factor: 6.600

10.  β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase.

Authors:  Hana Cernecka; Kim Kersten; Harm Maarsingh; Carolina R Elzinga; Igle Jan de Jong; Cees Korstanje; Martin C Michel; Martina Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-09       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.